Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.01 per share
-
Shares outstanding
-
95,992,895
-
Total 13F shares
-
78,709,574
-
Share change
-
+5,280,954
-
Total reported value
-
$827,347,590
-
Put/Call ratio
-
48%
-
Price per share
-
$10.51
-
Number of holders
-
153
-
Value change
-
+$46,727,000
-
Number of buys
-
86
-
Number of sells
-
79
Institutional Holders of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) as of Q4 2024
As of 31 Dec 2024,
AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,709,574 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, GENDELL JEFFREY L, BlackRock, Inc., Polar Capital Holdings Plc, Two Seas Capital LP, BRAIDWELL LP, VANGUARD GROUP INC, Vivo Capital, LLC, CITADEL ADVISORS LLC, and WEALTH EFFECTS LLC.
This page lists
154
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.